what to expect after taking semaglutide for Weight Loss: Timeline & How Do You Know When

Figure from Rossing et al NDT 2023 Primary Outcome This was a composite of time of first occurrence of: Onset of kidney failure (persistent eGFR 28 days or initiation of long-term KRT, kidney transplantation) Persistent 50% reduction in eGFR from baseline Death from kidney or CV causes Secondary Outcomes Confirmatory secondary outcomes were analyzed hierarchically

GLP-1 has a major impact on glucose management, and semaglutide has an analog structure and simulates all the activities of GLP-1

Aggregated Alpha-Synuclein inclusions within the nucleus predict impending neuronal cell death in a mouse model of parkinsonism

spending on prescription drugs soared past $800 billion, much of it driven by GLP-1 therapies

Several companies used REMS-related distribution restrictions specifically to delay generic entry

John Trojanowski (University of Pennsylvania)